Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EAN 2022
ESOC 2022
AAN 2022
CONy 2022
AD/PD 2022
World Sleep 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Filip Scheperjans
9:12
Brain-first and body-first Parkinson’s disease: are there subgroups of prodromal patients?
Filip Scheperjans
• 1 Jun 2021
1:52
Microbiota-targeting agents for Parkinson’s disease
Filip Scheperjans
• 1 Jun 2021
3:21
Can we achieve a clinically actionable test of the gut microbiome for neurodegenerative disorders?
Filip Scheperjans
• 1 Jun 2021
2:59
Investigating the gut microbiome in Parkinson’s disease
Filip Scheperjans
• 1 Jun 2021
3:30
Proof of concept trial: fecal microbiome transplantation in Parkinson’s disease
Filip Scheperjans
• 1 Jun 2021